Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 3.51% | 52.43 | 0.9% | $1363.76m | |
| JNJ | Johnson & Johnson | 1.74% | 176.97 | 0.7% | $1352.49m | |
| BMY | Bristol-Myers Squibb Co. | 0.36% | 76.23 | 1.0% | $1197.90m | |
| ABBV | AbbVie, Inc. | -0.53% | 150.92 | 1.9% | $1137.44m | |
| MRK | Merck & Co., Inc. | 1.26% | 93.25 | 0.7% | $1136.00m | |
| LLY | Eli Lilly & Co. | 4.49% | 299.11 | 1.1% | $892.99m | |
| AZN | AstraZeneca Plc | 2.59% | 66.21 | 1.0% | $517.65m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.65% | 141.96 | 0.0% | $458.27m | |
| VERU | Veru, Inc. | -6.37% | 13.38 | 0.0% | $318.66m | |
| NVS | Novartis AG | 0.86% | 89.41 | 0.2% | $251.17m | |
| GSK | GlaxoSmithKline Plc | 2.23% | 44.53 | 0.2% | $243.21m | |
| HZNP | Horizon Therapeutics Plc | 1.13% | 90.35 | 5.4% | $200.40m | |
| NVO | Novo Nordisk A/S | 3.49% | 107.68 | 0.1% | $190.60m | |
| SGEN | Seagen Inc. | -2.10% | 139.64 | 5.7% | $181.75m | |
| VTRS | Viatris, Inc. | 0.94% | 11.80 | 0.0% | $166.13m |
Company Profile
Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in Morristown, NJ.